Hop­ing to shake Al­ler­gan/Shire's dry eye dom­i­nance, Oys­ter Point posts pos­i­tive Phase IIb da­ta for ri­val drug

When pa­tients go to the eye doc com­plain­ing of dry, itchy eyes, they’re usu­al­ly giv­en some lu­bri­cat­ing eye drops and per­haps a low-dose steroid to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.